Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3414)
Arcutis Biotherapeutics, Inc. (ARQT)
Matsuda Masaru — Reporting Person's title: EVP, Chief Legal Officer
Shares
1,230
Price
$26.12
Total Value
$32.12K
Shares Held After
126,171
% of Holdings
1.0%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
100
Price
$97.10
Total Value
$9.71K
Shares Held After
97,994
% of Holdings
0.1%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
2,300
Price
$96.30
Total Value
$221.49K
Shares Held After
98,094
% of Holdings
2.3%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
5,100
Price
$95.21
Total Value
$485.57K
Shares Held After
100,394
% of Holdings
4.8%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
16
Price
$97.46
Total Value
$1.56K
Shares Held After
567,540
% of Holdings
0.0%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
1,392
Price
$96.82
Total Value
$134.77K
Shares Held After
567,556
% of Holdings
0.2%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
5,635
Price
$95.93
Total Value
$540.57K
Shares Held After
568,948
% of Holdings
1.0%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
7,157
Price
$95.10
Total Value
$680.63K
Shares Held After
574,583
% of Holdings
1.2%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
800
Price
$93.97
Total Value
$75.18K
Shares Held After
581,740
% of Holdings
0.1%
Septerna, Inc. (SEPN)
Long Daniel D. — SVP, Drug Discovery
Shares
2,334
Price
$34.68
Total Value
$80.94K
Shares Held After
96,412
% of Holdings
2.4%
Septerna, Inc. (SEPN)
Long Daniel D. — SVP, Drug Discovery
Shares
1,000
Price
$33.98
Total Value
$33.98K
Shares Held After
98,746
% of Holdings
1.0%
ALUMIS INC. (ALMS)
Goldstein David M — Chief Scientific Officer
Shares
2,596
Price
$26.37
Total Value
$68.46K
Shares Held After
30,970
% of Holdings
7.7%
ALUMIS INC. (ALMS)
Hardiman Roy C. — Chief Business&Strategy Ofcr
Shares
2,692
Price
$26.37
Total Value
$70.99K
Shares Held After
207,746
% of Holdings
1.3%
ALUMIS INC. (ALMS)
Schroer John R. — Chief Financial Officer
Shares
3,282
Price
$26.37
Total Value
$86.55K
Shares Held After
24,718
% of Holdings
11.7%
ALUMIS INC. (ALMS)
Pangali Sanam — Chief Legal Officer
Shares
1,364
Price
$26.37
Total Value
$35.97K
Shares Held After
9,747
% of Holdings
12.3%
ALUMIS INC. (ALMS)
Bradley Mark Christopher — Chief Development Officer
Shares
2,572
Price
$26.37
Total Value
$67.82K
Shares Held After
48,533
% of Holdings
5.0%
ALUMIS INC. (ALMS)
Drappa Jorn — Chief Medical Officer
Shares
2,447
Price
$26.37
Total Value
$64.53K
Shares Held After
56,892
% of Holdings
4.1%
CORCEPT THERAPEUTICS INC (CORT)
Lyon Joseph Douglas — Chief Accounting&Technology Officer
Shares
1,540
Price
$114.16
Total Value
$175.81K
Shares Held After
5,495
% of Holdings
21.9%
CORCEPT THERAPEUTICS INC (CORT)
Maduck Sean — President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission.
Shares
20,305
Price
$114.70
Total Value
$2.33M
Shares Held After
9,755
% of Holdings
67.5%
Camp4 Therapeutics Corp (CAMP)
Maricich Yuri — Chief Medical Officer
Shares
6,551
Price
$1.65
Total Value
$10.81K
Shares Held After
12,611
% of Holdings
51.9%
BeOne Medicines Ltd. (ONC)
Rosenberg Aaron — Chief Financial Officer
Shares
1,157
Price
$312.71
Total Value
$361.81K
Shares Held After
0
% of Holdings
100.0%
Camp4 Therapeutics Corp (CAMP)
Young Richard A — Director
Shares
16,378
Price
$1.65
Total Value
$27.02K
Shares Held After
186,388
% of Holdings
8.8%
Camp4 Therapeutics Corp (CAMP)
Gold Kelly — Chief Financial Officer
Shares
6,551
Price
$1.65
Total Value
$10.81K
Shares Held After
74,428
% of Holdings
8.8%
Vaxcyte, Inc. (PCVX)
Wassil Jim — CHIEF OPERATING OFFICER
Shares
1,389
Price
$54.09
Total Value
$75.13K
Shares Held After
157,541
% of Holdings
0.9%
Vaxcyte, Inc. (PCVX)
Wassil Jim — CHIEF OPERATING OFFICER
Shares
861
Price
$53.50
Total Value
$46.07K
Shares Held After
158,930
% of Holdings
0.5%
Vaxcyte, Inc. (PCVX)
GUGGENHIME ANDREW — PRESIDENT AND CFO
Shares
3,044
Price
$54.18
Total Value
$164.92K
Shares Held After
105,176
% of Holdings
2.8%
Vaxcyte, Inc. (PCVX)
GUGGENHIME ANDREW — PRESIDENT AND CFO
Shares
6,956
Price
$53.76
Total Value
$373.96K
Shares Held After
108,220
% of Holdings
6.0%
Camp4 Therapeutics Corp (CAMP)
Mandel-Brehm Josh — Director
Shares
6,551
Price
$1.65
Total Value
$10.81K
Shares Held After
284,968
% of Holdings
2.3%
Century Therapeutics, Inc. (IPSC)
Carr Douglas — SVP Finance&Operations
Shares
275
Price
$1.98
Total Value
$543.68
Shares Held After
504,819
% of Holdings
0.1%
Cocrystal Pharma, Inc. (COCP)
FROST PHILLIP MD ET AL — Director
Shares
75,000
Price
$0.94
Total Value
$70.59K
Shares Held After
1,983,551
% of Holdings
3.8%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
1,604
Price
$27.09
Total Value
$43.44K
Shares Held After
255,263
% of Holdings
0.6%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
30,304
Price
$26.71
Total Value
$809.54K
Shares Held After
256,867
% of Holdings
10.6%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
154
Price
$27.09
Total Value
$4.17K
Shares Held After
20,744
% of Holdings
0.7%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
2,439
Price
$26.71
Total Value
$65.16K
Shares Held After
20,898
% of Holdings
10.5%
Editas Medicine, Inc. (EDIT)
Parison Amy — SVP, Chief Financial Officer
Shares
678
Price
$2.58
Total Value
$1.75K
Shares Held After
14,292
% of Holdings
4.5%
Jazz Pharmaceuticals plc (JAZZ)
COZADD BRUCE C — Director
Shares
6,000
Price
$252.98
Total Value
$1.52M
Shares Held After
360,682
% of Holdings
1.6%
Stoke Therapeutics, Inc. (STOK)
Ticho Barry — CHIEF MEDICAL OFFICER
Shares
1,269
Price
$29.45
Total Value
$37.38K
Shares Held After
20,422
% of Holdings
5.9%
Stoke Therapeutics, Inc. (STOK)
Ticho Barry — CHIEF MEDICAL OFFICER
Shares
5,907
Price
$28.95
Total Value
$171.01K
Shares Held After
21,691
% of Holdings
21.4%
Tiziana Life Sciences Ltd (TLSA)
Elrifi Ivor — Chief Executive Officer
Shares
667,000
Price
$1.00
Total Value
$667.00K
Shares Held After
4,472,261
% of Holdings
14.9%
Mirum Pharmaceuticals, Inc. (MIRM)
Howe Jolanda — SVP, GLOBAL CONTROLLER
Shares
1,840
Price
$105.29
Total Value
$193.73K
Shares Held After
1,274
% of Holdings
59.1%
Verastem, Inc. (VSTM)
Paterson Dan — Director
Shares
1,302
Price
$5.81
Total Value
$7.56K
Shares Held After
589,940
% of Holdings
0.2%
Vericel Corp (VCEL)
Halpin Michael — Chief Operating Officer
Shares
10,000
Price
$46.84
Total Value
$468.40K
Shares Held After
16,394
% of Holdings
37.9%
Fortrea Holdings Inc. (FTRE)
SANDERS MACHELLE — Director
Shares
9,700
Price
$18.01
Total Value
$174.70K
Shares Held After
36,399
% of Holdings
21.0%
Imunon, Inc. (IMNN)
Eylward Susan — General Counsel and Corp Sec
Shares
2,541
Price
$1.57
Total Value
$3.98K
Shares Held After
2,896
% of Holdings
46.7%
MapLight Therapeutics, Inc. (MPLT)
Lillie James Woodruff — Chief Scientific Officer
Shares
22,082
Price
$12.54
Total Value
$276.91K
Shares Held After
202,380
% of Holdings
9.8%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
409
Price
$292.82
Total Value
$119.76K
Shares Held After
41,514
% of Holdings
1.0%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
991
Price
$291.71
Total Value
$289.09K
Shares Held After
41,923
% of Holdings
2.3%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
200
Price
$290.60
Total Value
$58.12K
Shares Held After
42,914
% of Holdings
0.5%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
503
Price
$289.80
Total Value
$145.77K
Shares Held After
43,114
% of Holdings
1.2%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
356
Price
$288.75
Total Value
$102.79K
Shares Held After
43,617
% of Holdings
0.8%
Showing 501–550 of 3414 transactions (page 11 of 69)